Many Nigerians have continued to decry the increasing price of drugs and called for an intervention from the Federal Government.

The reported exit of multinational consumer goods manufacturer, Procter & Gamble (P&G), is the latest among multinational companies that are forced to wind down operations in the country, due to the harsh operational environment.

The removal of fuel subsidy and the move to merge foreign exchange rates, two headline reforms introduced by the Tinubu administration since late May, triggered problems such as high fuel prices and the depreciation of the Naira

The nation has lost over 15 foreign businesses in the last three years to unfavourable environment, according to data from the Nigeria Employers’ Consultative Association (NECA).

Following closure of a British pharmaceutical giant, GlaxoSmithKline (GSK) and others in the country, President of Pharmaceutical Society of Nigeria (PSN), Prof. Cyril Odianose Usifoh, has charged the Federal Government on the production of Active...

Following the closure of a British pharmaceutical giant, GlaxoSmithKline (GSK) and other pharmaceutical companies in the country, the President of Pharmaceutical Society of Nigeria (PSN), Prof. Cyril Odianose Usifoh has urged the Federal Government (FG) to start the production of Active Pharmaceutical Ingredients (API). It also charged the FG to make drugs affordable and accessible…

Renowned for products such as Panadol, Lucozade, Ribena, Macleans and Sensodyne that a lot of Nigerians have grown fond of, the British pharmaceutical giant - GlaxoSmithKline Plc (GSK) - has called off its operations in Nigeria after about 52 years. The GSK UK Group has halted commercialising its prescription medicines and vaccines in Nigeria through…

Following increased appetite in MTN Nigeria Communications Plc (MTNN) and 24 other stocks, the Nigerian equities market reopened in an upbeat, yesterday, with market capitalisation gaining N75 billion.

The Managing Director, Merit Healthcare Limited and a fellow of the Pharmaceutical Society of Nigeria (PSN), Dr. Lolu Ojo, has explained why pharmaceutical firm, GlaxoSmithKline (GSK), ceased operations in Nigeria.

Lingering foreign exchange crisis, inflation, insecurity, high cost of operations coupled with uncertainty and fuel subsidy crisis have continued to take a toll on the operations of firms listed on the Nigerian Exchange Limited (NGX), triggering a gale of delisting.

Mr Peter Obi, the Presidential Candidate, Labour Party in the 2023 election, has decried the exit of the Pharmaceutical giant, GlaxoSmithKline (GSK), from Nigeria after 51 years of operations.

Nigerians may have begun to feel the inflationary impact of floating of the Naira as well as subsidy removal as prices of essential drugs and cost of care in the health sector have spiked lately, much to the discomfort of care seekers and practitioners.